nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—Methotrexate—colon cancer	0.326	1	CrCtD
Raltitrexed—TYMS—colon cancer	0.203	1	CbGaD
Raltitrexed—TYMS—Capecitabine—colon cancer	0.0805	0.352	CbGbCtD
Raltitrexed—FPGS—Methotrexate—colon cancer	0.0744	0.325	CbGbCtD
Raltitrexed—TYMS—Fluorouracil—colon cancer	0.0477	0.208	CbGbCtD
Raltitrexed—Pemetrexed—Methotrexate—colon cancer	0.0432	0.2	CrCrCtD
Raltitrexed—Tetrahydrofolic acid—Methotrexate—colon cancer	0.0432	0.2	CrCrCtD
Raltitrexed—Folic Acid—Methotrexate—colon cancer	0.0432	0.2	CrCrCtD
Raltitrexed—Pralatrexate—Methotrexate—colon cancer	0.0432	0.2	CrCrCtD
Raltitrexed—Leucovorin—Methotrexate—colon cancer	0.0432	0.2	CrCrCtD
Raltitrexed—TYMS—Methotrexate—colon cancer	0.0263	0.115	CbGbCtD
Raltitrexed—FPGS—lymphoid tissue—colon cancer	0.000484	0.12	CbGeAlD
Raltitrexed—FPGS—digestive system—colon cancer	0.000479	0.119	CbGeAlD
Raltitrexed—TYMS—Vinorelbine—Vincristine—colon cancer	0.000475	0.593	CbGdCrCtD
Raltitrexed—Leucovorin—TYMS—colon cancer	0.000455	0.298	CrCbGaD
Raltitrexed—Pralatrexate—TYMS—colon cancer	0.000455	0.298	CrCbGaD
Raltitrexed—Febrile neutropenia—Vincristine—colon cancer	0.000432	0.0236	CcSEcCtD
Raltitrexed—FPGS—vagina—colon cancer	0.000423	0.105	CbGeAlD
Raltitrexed—Febrile neutropenia—Irinotecan—colon cancer	0.000421	0.0229	CcSEcCtD
Raltitrexed—Sinus tachycardia—Capecitabine—colon cancer	0.000421	0.0229	CcSEcCtD
Raltitrexed—Febrile neutropenia—Fluorouracil—colon cancer	0.000403	0.022	CcSEcCtD
Raltitrexed—TYMS—smooth muscle tissue—colon cancer	0.000398	0.0988	CbGeAlD
Raltitrexed—Pemetrexed—TYMS—colon cancer	0.000364	0.238	CrCbGaD
Raltitrexed—FPGS—liver—colon cancer	0.000357	0.0886	CbGeAlD
Raltitrexed—TYMS—Vinblastine—Vincristine—colon cancer	0.000327	0.408	CbGdCrCtD
Raltitrexed—TYMS—lymphoid tissue—colon cancer	0.000318	0.079	CbGeAlD
Raltitrexed—TYMS—digestive system—colon cancer	0.000314	0.078	CbGeAlD
Raltitrexed—Necrosis—Fluorouracil—colon cancer	0.000309	0.0168	CcSEcCtD
Raltitrexed—Extravasation—Vincristine—colon cancer	0.000298	0.0162	CcSEcCtD
Raltitrexed—Extravasation—Irinotecan—colon cancer	0.00029	0.0158	CcSEcCtD
Raltitrexed—TYMS—bone marrow—colon cancer	0.000289	0.0719	CbGeAlD
Raltitrexed—Febrile neutropenia—Capecitabine—colon cancer	0.000282	0.0154	CcSEcCtD
Raltitrexed—Extravasation—Fluorouracil—colon cancer	0.000278	0.0152	CcSEcCtD
Raltitrexed—TYMS—vagina—colon cancer	0.000277	0.0689	CbGeAlD
Raltitrexed—FPGS—lymph node—colon cancer	0.000273	0.0679	CbGeAlD
Raltitrexed—Cellulitis—Fluorouracil—colon cancer	0.000267	0.0145	CcSEcCtD
Raltitrexed—Supraventricular tachycardia—Capecitabine—colon cancer	0.000259	0.0141	CcSEcCtD
Raltitrexed—Mouth ulceration—Vincristine—colon cancer	0.000235	0.0128	CcSEcCtD
Raltitrexed—TYMS—liver—colon cancer	0.000234	0.0581	CbGeAlD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TYMS—colon cancer	0.000221	0.136	CbGpPWpGaD
Raltitrexed—Sepsis—Irinotecan—colon cancer	0.00022	0.012	CcSEcCtD
Raltitrexed—Sepsis—Fluorouracil—colon cancer	0.000211	0.0115	CcSEcCtD
Raltitrexed—Hepatic failure—Vincristine—colon cancer	0.00021	0.0115	CcSEcCtD
Raltitrexed—Febrile neutropenia—Methotrexate—colon cancer	0.00021	0.0114	CcSEcCtD
Raltitrexed—Methotrexate—TYMS—colon cancer	0.000201	0.131	CrCbGaD
Raltitrexed—Renal impairment—Irinotecan—colon cancer	0.000193	0.0105	CcSEcCtD
Raltitrexed—Cellulitis—Capecitabine—colon cancer	0.000186	0.0102	CcSEcCtD
Raltitrexed—TYMS—lymph node—colon cancer	0.000179	0.0446	CbGeAlD
Raltitrexed—Dehydration—Vincristine—colon cancer	0.000176	0.00957	CcSEcCtD
Raltitrexed—Dehydration—Irinotecan—colon cancer	0.000171	0.00932	CcSEcCtD
Raltitrexed—Influenza like illness—Capecitabine—colon cancer	0.000165	0.00897	CcSEcCtD
Raltitrexed—Skin exfoliation—Capecitabine—colon cancer	0.000162	0.00882	CcSEcCtD
Raltitrexed—Necrosis—Methotrexate—colon cancer	0.000161	0.00876	CcSEcCtD
Raltitrexed—Mouth ulceration—Capecitabine—colon cancer	0.000153	0.00835	CcSEcCtD
Raltitrexed—Neutropenia—Vincristine—colon cancer	0.000153	0.00832	CcSEcCtD
Raltitrexed—Neutropenia—Irinotecan—colon cancer	0.000149	0.0081	CcSEcCtD
Raltitrexed—Weight decreased—Vincristine—colon cancer	0.000148	0.00805	CcSEcCtD
Raltitrexed—Sepsis—Capecitabine—colon cancer	0.000147	0.00802	CcSEcCtD
Raltitrexed—Extravasation—Methotrexate—colon cancer	0.000145	0.00788	CcSEcCtD
Raltitrexed—Weight decreased—Irinotecan—colon cancer	0.000144	0.00784	CcSEcCtD
Raltitrexed—Stomatitis—Vincristine—colon cancer	0.000142	0.00773	CcSEcCtD
Raltitrexed—Sweating—Vincristine—colon cancer	0.00014	0.0076	CcSEcCtD
Raltitrexed—Renal failure—Irinotecan—colon cancer	0.000139	0.00759	CcSEcCtD
Raltitrexed—Stomatitis—Irinotecan—colon cancer	0.000138	0.00753	CcSEcCtD
Raltitrexed—Hepatic failure—Capecitabine—colon cancer	0.000137	0.00746	CcSEcCtD
Raltitrexed—Sweating—Irinotecan—colon cancer	0.000136	0.0074	CcSEcCtD
Raltitrexed—Stomatitis—Fluorouracil—colon cancer	0.000132	0.00721	CcSEcCtD
Raltitrexed—Conjunctivitis—Fluorouracil—colon cancer	0.000132	0.00719	CcSEcCtD
Raltitrexed—Atrial fibrillation—Capecitabine—colon cancer	0.00013	0.00708	CcSEcCtD
Raltitrexed—Renal impairment—Capecitabine—colon cancer	0.000129	0.00705	CcSEcCtD
Raltitrexed—Skin exfoliation—Methotrexate—colon cancer	0.000121	0.00657	CcSEcCtD
Raltitrexed—Alopecia—Vincristine—colon cancer	0.000115	0.00629	CcSEcCtD
Raltitrexed—Dehydration—Capecitabine—colon cancer	0.000114	0.00624	CcSEcCtD
Raltitrexed—Mouth ulceration—Methotrexate—colon cancer	0.000114	0.00622	CcSEcCtD
Raltitrexed—Arrhythmia—Irinotecan—colon cancer	0.000114	0.00619	CcSEcCtD
Raltitrexed—Alopecia—Irinotecan—colon cancer	0.000112	0.00613	CcSEcCtD
Raltitrexed—Sepsis—Methotrexate—colon cancer	0.00011	0.00597	CcSEcCtD
Raltitrexed—Arrhythmia—Fluorouracil—colon cancer	0.000109	0.00593	CcSEcCtD
Raltitrexed—Alopecia—Fluorouracil—colon cancer	0.000108	0.00587	CcSEcCtD
Raltitrexed—Anaemia—Vincristine—colon cancer	0.000105	0.00573	CcSEcCtD
Raltitrexed—Ill-defined disorder—Irinotecan—colon cancer	0.000103	0.0056	CcSEcCtD
Raltitrexed—Anaemia—Irinotecan—colon cancer	0.000102	0.00558	CcSEcCtD
Raltitrexed—Hepatic failure—Methotrexate—colon cancer	0.000102	0.00556	CcSEcCtD
Raltitrexed—Leukopenia—Vincristine—colon cancer	0.000102	0.00555	CcSEcCtD
Raltitrexed—Malaise—Irinotecan—colon cancer	9.99e-05	0.00544	CcSEcCtD
Raltitrexed—Neutropenia—Capecitabine—colon cancer	9.95e-05	0.00542	CcSEcCtD
Raltitrexed—Leukopenia—Irinotecan—colon cancer	9.91e-05	0.0054	CcSEcCtD
Raltitrexed—Anaemia—Fluorouracil—colon cancer	9.81e-05	0.00534	CcSEcCtD
Raltitrexed—Cough—Irinotecan—colon cancer	9.67e-05	0.00527	CcSEcCtD
Raltitrexed—Weight decreased—Capecitabine—colon cancer	9.63e-05	0.00524	CcSEcCtD
Raltitrexed—Leukopenia—Fluorouracil—colon cancer	9.5e-05	0.00517	CcSEcCtD
Raltitrexed—Renal failure—Capecitabine—colon cancer	9.33e-05	0.00508	CcSEcCtD
Raltitrexed—Discomfort—Irinotecan—colon cancer	9.32e-05	0.00508	CcSEcCtD
Raltitrexed—Oedema—Vincristine—colon cancer	9.28e-05	0.00506	CcSEcCtD
Raltitrexed—Stomatitis—Capecitabine—colon cancer	9.25e-05	0.00504	CcSEcCtD
Raltitrexed—Infection—Vincristine—colon cancer	9.22e-05	0.00502	CcSEcCtD
Raltitrexed—Conjunctivitis—Capecitabine—colon cancer	9.22e-05	0.00502	CcSEcCtD
Raltitrexed—Thrombocytopenia—Vincristine—colon cancer	9.09e-05	0.00495	CcSEcCtD
Raltitrexed—Oedema—Irinotecan—colon cancer	9.04e-05	0.00493	CcSEcCtD
Raltitrexed—Infection—Irinotecan—colon cancer	8.98e-05	0.00489	CcSEcCtD
Raltitrexed—Hyperhidrosis—Vincristine—colon cancer	8.97e-05	0.00489	CcSEcCtD
Raltitrexed—Discomfort—Fluorouracil—colon cancer	8.92e-05	0.00486	CcSEcCtD
Raltitrexed—Thrombocytopenia—Irinotecan—colon cancer	8.85e-05	0.00482	CcSEcCtD
Raltitrexed—Anorexia—Vincristine—colon cancer	8.85e-05	0.00482	CcSEcCtD
Raltitrexed—Hyperhidrosis—Irinotecan—colon cancer	8.74e-05	0.00476	CcSEcCtD
Raltitrexed—Oedema—Fluorouracil—colon cancer	8.66e-05	0.00472	CcSEcCtD
Raltitrexed—Anorexia—Irinotecan—colon cancer	8.62e-05	0.0047	CcSEcCtD
Raltitrexed—Infection—Fluorouracil—colon cancer	8.6e-05	0.00469	CcSEcCtD
Raltitrexed—Thrombocytopenia—Fluorouracil—colon cancer	8.48e-05	0.00462	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Vincristine—colon cancer	8.46e-05	0.00461	CcSEcCtD
Raltitrexed—Anorexia—Fluorouracil—colon cancer	8.25e-05	0.0045	CcSEcCtD
Raltitrexed—Decreased appetite—Vincristine—colon cancer	8.07e-05	0.0044	CcSEcCtD
Raltitrexed—Dyspepsia—Irinotecan—colon cancer	7.96e-05	0.00434	CcSEcCtD
Raltitrexed—Constipation—Vincristine—colon cancer	7.94e-05	0.00433	CcSEcCtD
Raltitrexed—Pain—Vincristine—colon cancer	7.94e-05	0.00433	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Fluorouracil—colon cancer	7.89e-05	0.0043	CcSEcCtD
Raltitrexed—Decreased appetite—Irinotecan—colon cancer	7.86e-05	0.00428	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	7.78e-05	0.0478	CbGpPWpGaD
Raltitrexed—Pain—Irinotecan—colon cancer	7.73e-05	0.00421	CcSEcCtD
Raltitrexed—Constipation—Irinotecan—colon cancer	7.73e-05	0.00421	CcSEcCtD
Raltitrexed—Dyspepsia—Fluorouracil—colon cancer	7.62e-05	0.00415	CcSEcCtD
Raltitrexed—Arrhythmia—Capecitabine—colon cancer	7.61e-05	0.00415	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Vincristine—colon cancer	7.59e-05	0.00414	CcSEcCtD
Raltitrexed—Decreased appetite—Fluorouracil—colon cancer	7.53e-05	0.0041	CcSEcCtD
Raltitrexed—Alopecia—Capecitabine—colon cancer	7.53e-05	0.0041	CcSEcCtD
Raltitrexed—Feeling abnormal—Irinotecan—colon cancer	7.45e-05	0.00406	CcSEcCtD
Raltitrexed—Neutropenia—Methotrexate—colon cancer	7.41e-05	0.00404	CcSEcCtD
Raltitrexed—Pain—Fluorouracil—colon cancer	7.4e-05	0.00403	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Irinotecan—colon cancer	7.39e-05	0.00403	CcSEcCtD
Raltitrexed—Abdominal pain—Vincristine—colon cancer	7.34e-05	0.004	CcSEcCtD
Raltitrexed—Body temperature increased—Vincristine—colon cancer	7.34e-05	0.004	CcSEcCtD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—colon cancer	7.33e-05	0.045	CbGpPWpGaD
Raltitrexed—Dysgeusia—Capecitabine—colon cancer	7.26e-05	0.00396	CcSEcCtD
Raltitrexed—Abdominal pain—Irinotecan—colon cancer	7.15e-05	0.00389	CcSEcCtD
Raltitrexed—Body temperature increased—Irinotecan—colon cancer	7.15e-05	0.00389	CcSEcCtD
Raltitrexed—Feeling abnormal—Fluorouracil—colon cancer	7.13e-05	0.00389	CcSEcCtD
Raltitrexed—Renal failure—Methotrexate—colon cancer	6.94e-05	0.00378	CcSEcCtD
Raltitrexed—Stomatitis—Methotrexate—colon cancer	6.88e-05	0.00375	CcSEcCtD
Raltitrexed—Ill-defined disorder—Capecitabine—colon cancer	6.88e-05	0.00375	CcSEcCtD
Raltitrexed—Conjunctivitis—Methotrexate—colon cancer	6.86e-05	0.00374	CcSEcCtD
Raltitrexed—Anaemia—Capecitabine—colon cancer	6.85e-05	0.00373	CcSEcCtD
Raltitrexed—Body temperature increased—Fluorouracil—colon cancer	6.84e-05	0.00373	CcSEcCtD
Raltitrexed—Sweating—Methotrexate—colon cancer	6.77e-05	0.00369	CcSEcCtD
Raltitrexed—Malaise—Capecitabine—colon cancer	6.69e-05	0.00364	CcSEcCtD
Raltitrexed—Asthenia—Vincristine—colon cancer	6.66e-05	0.00363	CcSEcCtD
Raltitrexed—Leukopenia—Capecitabine—colon cancer	6.64e-05	0.00362	CcSEcCtD
Raltitrexed—Asthenia—Irinotecan—colon cancer	6.49e-05	0.00353	CcSEcCtD
Raltitrexed—Cough—Capecitabine—colon cancer	6.47e-05	0.00352	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CA7—colon cancer	6.42e-05	0.0394	CbGpPWpGaD
Raltitrexed—Diarrhoea—Vincristine—colon cancer	6.35e-05	0.00346	CcSEcCtD
Raltitrexed—Arthralgia—Capecitabine—colon cancer	6.31e-05	0.00344	CcSEcCtD
Raltitrexed—Discomfort—Capecitabine—colon cancer	6.24e-05	0.0034	CcSEcCtD
Raltitrexed—Diarrhoea—Irinotecan—colon cancer	6.19e-05	0.00337	CcSEcCtD
Raltitrexed—Pruritus—Fluorouracil—colon cancer	6.13e-05	0.00334	CcSEcCtD
Raltitrexed—Oedema—Capecitabine—colon cancer	6.05e-05	0.0033	CcSEcCtD
Raltitrexed—Infection—Capecitabine—colon cancer	6.01e-05	0.00328	CcSEcCtD
Raltitrexed—Diarrhoea—Fluorouracil—colon cancer	5.92e-05	0.00323	CcSEcCtD
Raltitrexed—Thrombocytopenia—Capecitabine—colon cancer	5.92e-05	0.00323	CcSEcCtD
Raltitrexed—Vomiting—Vincristine—colon cancer	5.9e-05	0.00322	CcSEcCtD
Raltitrexed—Rash—Vincristine—colon cancer	5.85e-05	0.00319	CcSEcCtD
Raltitrexed—Hyperhidrosis—Capecitabine—colon cancer	5.85e-05	0.00319	CcSEcCtD
Raltitrexed—Dermatitis—Vincristine—colon cancer	5.85e-05	0.00319	CcSEcCtD
Raltitrexed—Headache—Vincristine—colon cancer	5.82e-05	0.00317	CcSEcCtD
Raltitrexed—Anorexia—Capecitabine—colon cancer	5.77e-05	0.00314	CcSEcCtD
Raltitrexed—Vomiting—Irinotecan—colon cancer	5.75e-05	0.00313	CcSEcCtD
Raltitrexed—Rash—Irinotecan—colon cancer	5.7e-05	0.00311	CcSEcCtD
Raltitrexed—Dermatitis—Irinotecan—colon cancer	5.69e-05	0.0031	CcSEcCtD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	5.67e-05	0.0348	CbGpPWpGaD
Raltitrexed—Headache—Irinotecan—colon cancer	5.66e-05	0.00309	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	5.62e-05	0.0345	CbGpPWpGaD
Raltitrexed—Alopecia—Methotrexate—colon cancer	5.6e-05	0.00305	CcSEcCtD
Raltitrexed—Nausea—Vincristine—colon cancer	5.51e-05	0.003	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Capecitabine—colon cancer	5.51e-05	0.003	CcSEcCtD
Raltitrexed—Vomiting—Fluorouracil—colon cancer	5.5e-05	0.003	CcSEcCtD
Raltitrexed—Rash—Fluorouracil—colon cancer	5.46e-05	0.00297	CcSEcCtD
Raltitrexed—Dermatitis—Fluorouracil—colon cancer	5.45e-05	0.00297	CcSEcCtD
Raltitrexed—Headache—Fluorouracil—colon cancer	5.42e-05	0.00296	CcSEcCtD
Raltitrexed—Dysgeusia—Methotrexate—colon cancer	5.4e-05	0.00294	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—TOP1—colon cancer	5.39e-05	0.0331	CbGpPWpGaD
Raltitrexed—Nausea—Irinotecan—colon cancer	5.37e-05	0.00293	CcSEcCtD
Raltitrexed—Dyspepsia—Capecitabine—colon cancer	5.33e-05	0.0029	CcSEcCtD
Raltitrexed—Decreased appetite—Capecitabine—colon cancer	5.26e-05	0.00287	CcSEcCtD
Raltitrexed—Pain—Capecitabine—colon cancer	5.17e-05	0.00282	CcSEcCtD
Raltitrexed—Constipation—Capecitabine—colon cancer	5.17e-05	0.00282	CcSEcCtD
Raltitrexed—Nausea—Fluorouracil—colon cancer	5.14e-05	0.0028	CcSEcCtD
Raltitrexed—Ill-defined disorder—Methotrexate—colon cancer	5.12e-05	0.00279	CcSEcCtD
Raltitrexed—Anaemia—Methotrexate—colon cancer	5.1e-05	0.00278	CcSEcCtD
Raltitrexed—Methotrexate—ABCB1—colon cancer	5.09e-05	0.0333	CrCbGaD
Raltitrexed—Feeling abnormal—Capecitabine—colon cancer	4.99e-05	0.00272	CcSEcCtD
Raltitrexed—Malaise—Methotrexate—colon cancer	4.98e-05	0.00271	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Capecitabine—colon cancer	4.95e-05	0.0027	CcSEcCtD
Raltitrexed—Leukopenia—Methotrexate—colon cancer	4.94e-05	0.00269	CcSEcCtD
Raltitrexed—Cough—Methotrexate—colon cancer	4.82e-05	0.00262	CcSEcCtD
Raltitrexed—Abdominal pain—Capecitabine—colon cancer	4.78e-05	0.00261	CcSEcCtD
Raltitrexed—Body temperature increased—Capecitabine—colon cancer	4.78e-05	0.00261	CcSEcCtD
Raltitrexed—Arthralgia—Methotrexate—colon cancer	4.7e-05	0.00256	CcSEcCtD
Raltitrexed—FPGS—Disease—CHST5—colon cancer	4.64e-05	0.0285	CbGpPWpGaD
Raltitrexed—FPGS—Disease—LGR5—colon cancer	4.64e-05	0.0285	CbGpPWpGaD
Raltitrexed—Discomfort—Methotrexate—colon cancer	4.64e-05	0.00253	CcSEcCtD
Raltitrexed—Infection—Methotrexate—colon cancer	4.47e-05	0.00244	CcSEcCtD
Raltitrexed—Thrombocytopenia—Methotrexate—colon cancer	4.41e-05	0.0024	CcSEcCtD
Raltitrexed—Hyperhidrosis—Methotrexate—colon cancer	4.35e-05	0.00237	CcSEcCtD
Raltitrexed—Asthenia—Capecitabine—colon cancer	4.34e-05	0.00237	CcSEcCtD
Raltitrexed—Anorexia—Methotrexate—colon cancer	4.29e-05	0.00234	CcSEcCtD
Raltitrexed—Pruritus—Capecitabine—colon cancer	4.28e-05	0.00233	CcSEcCtD
Raltitrexed—Diarrhoea—Capecitabine—colon cancer	4.14e-05	0.00226	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Methotrexate—colon cancer	4.1e-05	0.00224	CcSEcCtD
Raltitrexed—Dyspepsia—Methotrexate—colon cancer	3.96e-05	0.00216	CcSEcCtD
Raltitrexed—Decreased appetite—Methotrexate—colon cancer	3.92e-05	0.00213	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ODC1—colon cancer	3.89e-05	0.0239	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CHST5—colon cancer	3.89e-05	0.0239	CbGpPWpGaD
Raltitrexed—Pain—Methotrexate—colon cancer	3.85e-05	0.0021	CcSEcCtD
Raltitrexed—Vomiting—Capecitabine—colon cancer	3.85e-05	0.0021	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	3.83e-05	0.0235	CbGpPWpGaD
Raltitrexed—Rash—Capecitabine—colon cancer	3.81e-05	0.00208	CcSEcCtD
Raltitrexed—Dermatitis—Capecitabine—colon cancer	3.81e-05	0.00208	CcSEcCtD
Raltitrexed—Headache—Capecitabine—colon cancer	3.79e-05	0.00207	CcSEcCtD
Raltitrexed—Feeling abnormal—Methotrexate—colon cancer	3.71e-05	0.00202	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Methotrexate—colon cancer	3.68e-05	0.00201	CcSEcCtD
Raltitrexed—Nausea—Capecitabine—colon cancer	3.59e-05	0.00196	CcSEcCtD
Raltitrexed—Body temperature increased—Methotrexate—colon cancer	3.56e-05	0.00194	CcSEcCtD
Raltitrexed—Abdominal pain—Methotrexate—colon cancer	3.56e-05	0.00194	CcSEcCtD
Raltitrexed—FPGS—Disease—AXIN2—colon cancer	3.34e-05	0.0205	CbGpPWpGaD
Raltitrexed—Asthenia—Methotrexate—colon cancer	3.23e-05	0.00176	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.23e-05	0.0198	CbGpPWpGaD
Raltitrexed—Pruritus—Methotrexate—colon cancer	3.19e-05	0.00174	CcSEcCtD
Raltitrexed—Diarrhoea—Methotrexate—colon cancer	3.08e-05	0.00168	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—MLH3—colon cancer	2.98e-05	0.0183	CbGpPWpGaD
Raltitrexed—Vomiting—Methotrexate—colon cancer	2.86e-05	0.00156	CcSEcCtD
Raltitrexed—Rash—Methotrexate—colon cancer	2.84e-05	0.00155	CcSEcCtD
Raltitrexed—Dermatitis—Methotrexate—colon cancer	2.84e-05	0.00155	CcSEcCtD
Raltitrexed—Headache—Methotrexate—colon cancer	2.82e-05	0.00154	CcSEcCtD
Raltitrexed—Nausea—Methotrexate—colon cancer	2.68e-05	0.00146	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—colon cancer	2.67e-05	0.0164	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	2.58e-05	0.0158	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CA7—colon cancer	2.34e-05	0.0144	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDKN1A—colon cancer	2.08e-05	0.0128	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	2.01e-05	0.0124	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—EP300—colon cancer	1.98e-05	0.0121	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.91e-05	0.0117	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	1.87e-05	0.0115	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	1.81e-05	0.0111	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—MYC—colon cancer	1.72e-05	0.0106	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—CDKN1A—colon cancer	1.51e-05	0.00926	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—colon cancer	1.5e-05	0.0092	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.45e-05	0.00891	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CHST5—colon cancer	1.42e-05	0.0087	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ODC1—colon cancer	1.42e-05	0.0087	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—PPARG—colon cancer	1.34e-05	0.00825	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—colon cancer	1.31e-05	0.00807	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MLH1—colon cancer	1.31e-05	0.00806	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1A—colon cancer	1.27e-05	0.0078	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—MYC—colon cancer	1.25e-05	0.00768	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—BUB1B—colon cancer	1.25e-05	0.00766	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—colon cancer	1.23e-05	0.00755	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BUB1B—colon cancer	1.12e-05	0.00685	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.1e-05	0.00676	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—colon cancer	1.05e-05	0.00647	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ABCB1—colon cancer	1.03e-05	0.00631	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.02e-05	0.00628	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—TYMS—colon cancer	1.01e-05	0.00619	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	9.96e-06	0.00611	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	9.86e-06	0.00605	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	9.63e-06	0.00591	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR3—colon cancer	9.63e-06	0.00591	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	9.17e-06	0.00563	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	8.91e-06	0.00547	CbGpPWpGaD
Raltitrexed—FPGS—Disease—APC—colon cancer	8.84e-06	0.00543	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—EP300—colon cancer	8.8e-06	0.0054	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	8.68e-06	0.00533	CbGpPWpGaD
Raltitrexed—FPGS—Disease—BRAF—colon cancer	8.31e-06	0.0051	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	7.99e-06	0.0049	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	7.97e-06	0.00489	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	7.81e-06	0.00479	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	7.38e-06	0.00453	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PPARG—colon cancer	7.15e-06	0.00439	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.78e-06	0.00416	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTGS2—colon cancer	6.71e-06	0.00412	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.56e-06	0.00403	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—colon cancer	6.3e-06	0.00386	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CTNNB1—colon cancer	6.01e-06	0.00369	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1A—colon cancer	5.87e-06	0.0036	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTGS2—colon cancer	5.62e-06	0.00345	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EP300—colon cancer	5.58e-06	0.00343	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.54e-06	0.0034	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SRC—colon cancer	5.43e-06	0.00333	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NRAS—colon cancer	5.22e-06	0.00321	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—colon cancer	4.87e-06	0.00299	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFB1—colon cancer	4.85e-06	0.00298	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—colon cancer	4.82e-06	0.00296	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGFR—colon cancer	4.76e-06	0.00292	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—EP300—colon cancer	4.68e-06	0.00287	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—colon cancer	4.66e-06	0.00286	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—colon cancer	4.5e-06	0.00276	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—EP300—colon cancer	4.44e-06	0.00272	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—colon cancer	4.31e-06	0.00265	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1A—colon cancer	4.17e-06	0.00256	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—colon cancer	4.13e-06	0.00254	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—EP300—colon cancer	3.97e-06	0.00244	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—colon cancer	3.87e-06	0.00237	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—colon cancer	3.82e-06	0.00235	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCB1—colon cancer	3.74e-06	0.0023	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—colon cancer	3.46e-06	0.00212	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—colon cancer	3.46e-06	0.00212	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—colon cancer	3.37e-06	0.00207	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—colon cancer	2.84e-06	0.00174	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—colon cancer	2.83e-06	0.00173	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPARG—colon cancer	2.61e-06	0.0016	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS2—colon cancer	2.05e-06	0.00126	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—EP300—colon cancer	1.7e-06	0.00105	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—colon cancer	1.26e-06	0.000774	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—colon cancer	1.03e-06	0.000632	CbGpPWpGaD
